Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Conference Proceeding
|
31 Apical hypertrophic cardiomyopathy: the variant less knownHeart (British Cardiac Society), 2021, Vol.107 (Suppl 2), p.A27-A27 [Peer Reviewed Journal]2021 Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2021-ICS.31Full text available |
|
2 |
Material Type: Conference Proceeding
|
41 Promise or peril: the ECG in hypertrophic cardiomyopathyHeart (British Cardiac Society), 2022, Vol.108 (Suppl 3), p.A35-A35 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2022-ICS.41Full text available |
|
3 |
Material Type: Conference Proceeding
|
15 Clinical profile of transthyretin amyloid cardiomyopathy patients in IrelandHeart (British Cardiac Society), 2021, Vol.107 (Suppl 2), p.A16-A17 [Peer Reviewed Journal]2021 Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2021-ICS.15Full text available |
|
4 |
Material Type: Conference Proceeding
|
13 Myocardial fibrosis entropy is associated with life-threatening arrhythmia in non-ischaemic cardiomyopathyHeart (British Cardiac Society), 2023, Vol.109 (Suppl 1), p.A10-A10 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2022-BSCMR.13Full text available |
|
5 |
Material Type: Conference Proceeding
|
12 Prevalence of transthyretin amyloid cardiomyopathy (aTTR-CM) in undifferentiated HFpEFHeart (British Cardiac Society), 2022, Vol.108 (Suppl 3), p.A11-A11 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2022-ICS.12Full text available |
|
6 |
Material Type: Conference Proceeding
|
36 Phenotypic predictors of genotype positivity in probands with hypertrophic cardiomyopathy (HCM)Heart (British Cardiac Society), 2022, Vol.108 (Suppl 3), p.A31-A32 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2022-ICS.36Full text available |
|
7 |
Material Type: Conference Proceeding
|
16 Single-cell RNA sequencing reveals cardiac cell-specific transcriptomic changes in dilated cardiomyopathyHeart (British Cardiac Society), 2021, Vol.107 (Suppl 2), p.A17-A17 [Peer Reviewed Journal]2021 Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2021-ICS.16Full text available |
|
8 |
Material Type: Conference Proceeding
|
1 Microstructural & microvascular phenotype of hypertrophic cardiomyopathy – from mutation to hypertrophy; a multicentre collaborative study of 192-subjectsHeart (British Cardiac Society), 2023, Vol.109 (Suppl 1), p.A1-A2 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2022-BSCMR.1Full text available |
|
9 |
Material Type: Conference Proceeding
|
33 The therapeutic benefit of upgrade to cardiac resynchronization therapy in patients with pacing induced cardiomyopathyHeart (British Cardiac Society), 2022, Vol.108 (Suppl 3), p.A28-A29 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2022-ICS.33Full text available |
|
10 |
Material Type: Conference Proceeding
|
P3 Novel insights into diminished cardiac reserve in hypertrophic cardiomyopathy from 4D flow CMR component analysisHeart (British Cardiac Society), 2022, Vol.108 (Suppl 2), p.A3-A4 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2022-BSCI.8Full text available |
|
11 |
Material Type: Conference Proceeding
|
3 Beyond 15mm: towards a new personalised, AI measured definition of hypertrophic cardiomyopathy using an age, sex, and body surface area -adjusted approachHeart (British Cardiac Society), 2023, Vol.109 (Suppl 1), p.A3-A4 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2022-BSCMR.3Full text available |
|
12 |
Material Type: Conference Proceeding
|
19 Myocardial perfusion reserve by quantitative perfusion cardiovascular magnetic resonance in dilated cardiomyopathy: association with major adverse cardiovascular eventsHeart (British Cardiac Society), 2023, Vol.109 (Suppl 1), p.A16-A17 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2022-BSCMR.19Full text available |
|
13 |
Material Type: Conference Proceeding
|
T4 ERK5 degradation: a turning point from compensated metabolic cardiomyopathy to heart failureHeart (British Cardiac Society), 2018, Vol.104 (Suppl 3), p.A2 [Peer Reviewed Journal]2018, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2018-BSCR.4Full text available |
|
14 |
Material Type: Conference Proceeding
|
P12 A novel model of cardiomyopathy reveals a tissue specific role for the complex i assembly factor ecsitHeart (British Cardiac Society), 2018, Vol.104 (Suppl 3), p.A6 [Peer Reviewed Journal]2018, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2018-BSCR.17Full text available |
|
15 |
Material Type: Conference Proceeding
|
Cardiomyopathy in Marfan SyndromeThe Thoracic and Cardiovascular Surgeon, 2014 [Peer Reviewed Journal]ISSN: 0171-6425 ;EISSN: 1439-1902 ;DOI: 10.1055/s-0034-1367138Digital Resources/Online E-Resources |
|
16 |
Material Type: Conference Proceeding
|
Evaluation of arrhythmias using an insertable cardiac monitor in patients with hypertrophic cardiomyopathyEUROPEAN HEART JOURNAL, 2019, Vol.40, p.4169 [Peer Reviewed Journal]ISSN: 1522-9645 ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehz746.1163Full text available |
|
17 |
Material Type: Conference Proceeding
|
Left Ventricle Restoration in End Stage Ischemic Dilated CardiomyopathyAORTA, 2022, Vol.10 (S 01) [Peer Reviewed Journal]The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. ;EISSN: 2325-4637 ;DOI: 10.1055/s-0042-1750979Full text available |
|
18 |
Material Type: Conference Proceeding
|
Takotsubo Cardiomyopathy in a Heart Transplant RecipientChest, 2013, Vol.144 (4), p.124A-124B [Peer Reviewed Journal]The American College of Chest Physicians ;2013 The American College of Chest Physicians ;ISSN: 0012-3692 ;EISSN: 1931-3543 ;DOI: 10.1378/chest.1701735Full text available |
|
19 |
Material Type: Conference Proceeding
|
Pathophysiology measured with positron emission tomography is equally impaired in hypertrophic and non-hypertrophic regions in hypertrophic cardiomyopathyEUROPEAN HEART JOURNAL, 2019, Vol.40, p.1983 [Peer Reviewed Journal]ISSN: 1522-9645 ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehz745.0237Full text available |
|
20 |
Material Type: Conference Proceeding
|
Abstract 796: Reproductive hormones modulate cardioprotection from doxorubicin-induced cardiomyopathy in female spontaneously hypertensive ratsCancer research (Chicago, Ill.), 2017, Vol.77 (13_Supplement), p.796-796 [Peer Reviewed Journal]ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/1538-7445.AM2017-796Full text available |